Maggie handles a diverse range of chemical subject-matter including healthcare technology, consumer products, and polymeric products. She particularly focuses on patents for small molecules, antibody-drug conjugate therapies, hemostatic devices, contact lenses and green technologies (such as polymer manufacture, photovoltaic cells and renewable batteries). Maggie advises clients through all stages of the patent process, from the drafting of new applications, to coordinating prosecution of global patent portfolios, through to post-grant contentious matters. She particularly enjoys defending and opposing patents in opposition and appeal procedures at the European Patent Office, and has valuable experience providing support for multi-jurisdictional patent litigation disputes (both enforcement and the defence of nullity actions). Maggie works for both established multi-national companies and early-stage companies, and enjoys developing realistic IP strategies suitable for clients’ specific commercial objectives.
Maggie joined Carpmaels & Ransford in 2015, qualifying as a Chartered Patent Attorney in 2019. She graduated from the University of Cambridge with a degree in Natural Sciences (Chemistry), having studied a range of subjects across organic, physical and inorganic chemistry. She spent her final summer in the lab working on a fragment-based drug discovery approach to SMYD3, a methyl transferase epigenetic target. Maggie is an active member of the Chiefs in Intellectual Property (ChIPs) group.
Outside of the office, Maggie enjoys practicing yoga, attending a local book club, and trying her hand at wheel-thrown pottery. She is fluent in French, and likes to stay up to date through French cinema and podcasts.
- BA Natural Sciences (University of Cambridge)
- European Patent Attorney
- Chartered Patent Attorney
- CertIP Certificate in Intellectual Property Law
- European Patent Litigator